​

Denali Therapeutics Ownership | Who Owns Denali Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Denali Therapeutics Ownership Summary

Denali Therapeutics is owned by 84.28% institutional investors, 9.09% insiders, and 6.63% retail investors. Blackrock is the largest institutional shareholder, holding 8.82% of DNLI shares. Scottish Mortgage Ord is the top mutual fund, with 4.41% of its assets in Denali Therapeutics shares.

DNLI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDenali Therapeutics84.28%9.09%6.63%
SectorHealthcare Stocks 50.49%12.37%37.14%
IndustryBiotech Stocks 48.95%12.07%38.98%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock13.17M8.82%$305.91M
T. rowe price investment management16.18M8.67%$416.12M
Vanguard group13.06M7.57%$215.59M
Blackrock funding, inc. /de14.03M7.52%$360.76M
Baillie gifford11.96M6.41%$307.62M
State street7.05M3.78%$181.31M
Temasek (private)7.01M3.76%$180.37M
Vanguard capital management6.28M3.36%$161.41M
Fmr4.54M2.43%$116.66M
Goldman sachs group4.16M2.23%$106.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Crestline management, lp1.91M91.90%$49.14M
Foresite capital management vi1.40M5.59%$35.92M
Dafna capital management739.01K3.62%$19.01M
Casdin capital2.04M2.63%$52.60M
Cercano management625.00K1.55%$16.07M
Adar1 capital management1.03M1.21%$26.47M
Boxer capital management250.00K1.16%$3.63M
Privium fund management b.v.229.86K1.09%$5.91M
Yiheng capital management469.98K1.01%$6.82M
Lumbard & kellner98.28K0.77%$2.53M

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management16.18M0.27%7.66M
Norges bank2.82M0.01%2.82M
Macquarie management2.21M0.09%2.09M
Sixth street partners management company1.24M0.00%1.24M
Vanguard group13.06M0.00%1.06M

Top Sellers

HolderShares% AssetsChange
Lynx1 capital management lp11.66K0.06%-1.87M
Vestal point capital, lp---1.77M
Alyeska investment group219.33K0.01%-1.72M
Point72 asset management---1.70M
Flagship pioneering---1.36M

New Positions

HolderShares% AssetsChangeValue
Norges bank2.82M0.01%2.82M$72.65M
Sixth street partners management company1.24M0.00%1.24M$32.02M
Axa investment managers294.73K0.01%294.73K$4.28M
Schonfeld strategic advisors226.20K0.02%226.20K$3.28M
E. ohman j:or asset management ab160.00K0.10%160.00K$4.12M

Sold Out

HolderChange
Truvestments capital-1.00
Curio wealth-1.00
Vermillion wealth management-1.00
Toronto dominion bank-2.00
Global financial private client-5.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262985.67%157,296,9146.71%841.19%17911.18%6611.86%
Mar 31, 2026235-7.11%121,971,228-19.30%690.90%136-47-33.80%
Dec 31, 202569-71.60%34,419,053-74.60%190.32%37-70.63%15-76.92%
Sep 30, 202584-62.83%32,008,693-75.36%180.33%39-67.77%28-56.25%
Jun 30, 20252304.07%137,233,4273.48%801.33%12214.02%66-17.50%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Scottish Mortgage Ord7.04M4.41%-
T. Rowe Price Capital Appreciation4.97M3.13%4.97M
Vanguard Health Care Inv4.40M3.03%-5.17M
Vanguard Total Stock Mkt Idx Inv4.29M2.70%20.55K
Vanguard Morn Total Stk Mkt Idx Investor4.29M2.70%20.55K
Vanguard MStar Total Stk Mkt Idx Invest4.31M2.70%19.86K
iShares Russell 2000 ETF3.75M2.36%-66.62K
Vanguard US Total Market Shares ETF3.33M2.29%-161.11K
State Street® SPDR® S&P® Biotech ETF3.41M2.15%7.84K
Vanguard Small Cap Index3.10M1.94%9.44K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 11, 2026Schuth Alexander O. COFO and SecretarySell$71.62K
Jan 06, 2026Watts Ryan J. President and CEOSell$580.77K
Jan 06, 2026Schuth Alexander O. COFO and SecretarySell$284.10K
Dec 11, 2025BAKER BROS. ADVISORS LP-Buy$20.95K
Dec 11, 2025BAKER BROS. ADVISORS LP-Buy$1.91K

Insider Transactions Trends

DateBuySell
2026 Q3-1
2026 Q2--
2026 Q1-2
2025 Q42-
2025 Q3-4

DNLI Ownership FAQ

Who Owns Denali Therapeutics?

Denali Therapeutics shareholders are primarily institutional investors at 84.28%, followed by 9.09% insiders and 6.63% retail investors. The average institutional ownership in Denali Therapeutics's industry, Biotech Stocks , is 48.95%, which Denali Therapeutics exceeds.

Who owns the most shares of Denali Therapeutics?

Denali Therapeutics’s largest shareholders are Blackrock (13.17M shares, 8.82%), T. rowe price investment management (16.18M shares, 8.67%), and Vanguard group (13.06M shares, 7.57%). Together, they hold 25.06% of Denali Therapeutics’s total shares outstanding.

Does Blackrock own Denali Therapeutics?

Yes, BlackRock owns 8.82% of Denali Therapeutics, totaling 13.17M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 305.91M$. In the last quarter, BlackRock increased its holdings by 974.71K shares, a 7.99% change.

Who is Denali Therapeutics’s biggest shareholder by percentage of total assets invested?

Crestline management, lp is Denali Therapeutics’s biggest shareholder by percentage of total assets invested, with 91.90% of its assets in 1.91M Denali Therapeutics shares, valued at 49.14M$.

Who is the top mutual fund holder of Denali Therapeutics shares?

Scottish Mortgage Ord is the top mutual fund holder of Denali Therapeutics shares, with 4.41% of its total shares outstanding invested in 7.04M Denali Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools